Replies to post #36294 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

The global market value for Non-Small Cell Lung Cancer (NSCLC) treatment will increase from $6.9 billion in 2014 to $10.9 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 8.5%, says business intelligence provider GBI Research.

https://drug-dev.com/global-non-small-cell-lung-cancer-treatment-market-value-to-approach-11-billion/